Prostate cancer / / edited by Simon Bott, Keng Lim Ng.

Prostate cancer is a life-altering diagnosis, not just for patients, but for their loved ones as well. Once, prostate cancer was most frequently diagnosed in men in their 60s and 70s; with increasing use of imaging modalities and PSA testing, the incidence is on the rise, and we are now seeing men i...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:Brisbane, AU : : Exon Publications,, [2021]
©2021
Year of Publication:2021
Language:English
Physical Description:1 online resource (xiv, 157 pages) :; illustrations
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993548504904498
ctrlnum (CKB)4100000012155979
(NjHacI)994100000012155979
(oapen)https://directory.doabooks.org/handle/20.500.12854/81838.2
(EXLCZ)994100000012155979
collection bib_alma
record_format marc
spelling Prostate cancer / edited by Simon Bott, Keng Lim Ng.
Australia Exon Publications 2021
Brisbane, AU : Exon Publications, [2021]
©2021
1 online resource (xiv, 157 pages) : illustrations
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on: online resource; title from PDF information screen (NCBI, viewed November 05, 2022).
Includes bibliographical references.
Prostate cancer is a life-altering diagnosis, not just for patients, but for their loved ones as well. Once, prostate cancer was most frequently diagnosed in men in their 60s and 70s; with increasing use of imaging modalities and PSA testing, the incidence is on the rise, and we are now seeing men in their 40s with the disease. This poses a challenge for clinical management depending on the stage of the disease—from watchful waiting or active surveillance to aggressive treatment with the risk of therapeutic nihilism. Despite being one of the most common cancers in Western men, its natural history, prognosis, and treatment are poorly understood. This book brings together a select faculty of experts to present a comprehensive view of the current state and future perspectives of prostate cancer. There are ten chapters in the book—the first four cover our present knowledge and understanding of the disease, the following three explore new advancements and treatments, particularly looking at overcoming resistance to therapy, and the remaining three chapters focus on specific molecules with the potential to become drug targets. We all have much to learn about prostate cancer. This book is aimed primarily at clinicians and scientists, but many areas will also be of interest to the layperson.
English
Prostate Cancer.
Epidemiology of Prostate Cancer; Etiology of Prostate Cancer; Pathogenesis of Prostate Cancer; Current Diagnostics for Prostate Cancer; Combination Treatment for Prostate Cancer; Castration-Resistant Prostate Cancer; Theranostics in Metastatic Castrate Resistant Prostate Cancer; Adenocarcinoma of the Prostate; p53 in Prostate Cancer; MUCIN 1 in Prostate Cancer; STEAP Proteins in Prostate Cancer
0-645-00175-9
Bott, Simon, editor.
Ng, Keng Lim, editor.
language English
format eBook
author2 Bott, Simon,
Ng, Keng Lim,
author_facet Bott, Simon,
Ng, Keng Lim,
author2_variant s b sb
k l n kl kln
author2_role TeilnehmendeR
TeilnehmendeR
title Prostate cancer /
spellingShingle Prostate cancer /
title_full Prostate cancer / edited by Simon Bott, Keng Lim Ng.
title_fullStr Prostate cancer / edited by Simon Bott, Keng Lim Ng.
title_full_unstemmed Prostate cancer / edited by Simon Bott, Keng Lim Ng.
title_auth Prostate cancer /
title_new Prostate cancer /
title_sort prostate cancer /
publisher Exon Publications
Exon Publications,
publishDate 2021
physical 1 online resource (xiv, 157 pages) : illustrations
isbn 0-645-00175-9
callnumber-first R - Medicine
callnumber-subject RC - Internal Medicine
callnumber-label RC280
callnumber-sort RC 3280 P7 P767 42021
illustrated Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.99463
dewey-sort 3616.99463
dewey-raw 616.99463
dewey-search 616.99463
work_keys_str_mv AT bottsimon prostatecancer
AT ngkenglim prostatecancer
status_str n
ids_txt_mv (CKB)4100000012155979
(NjHacI)994100000012155979
(oapen)https://directory.doabooks.org/handle/20.500.12854/81838.2
(EXLCZ)994100000012155979
carrierType_str_mv cr
is_hierarchy_title Prostate cancer /
author2_original_writing_str_mv noLinkedField
noLinkedField
_version_ 1796649014768173056
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02995nam a2200385 i 4500</leader><controlfield tag="001">993548504904498</controlfield><controlfield tag="005">20230608020114.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr#|||||||||||</controlfield><controlfield tag="008">221105s2021 qeaa ob 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000012155979</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994100000012155979</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/81838.2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000012155979</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC280.P7</subfield><subfield code="b">.P767 2021</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.99463</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Prostate cancer /</subfield><subfield code="c">edited by Simon Bott, Keng Lim Ng.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Australia</subfield><subfield code="b">Exon Publications</subfield><subfield code="c">2021</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Brisbane, AU :</subfield><subfield code="b">Exon Publications,</subfield><subfield code="c">[2021]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xiv, 157 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (NCBI, viewed November 05, 2022).</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Prostate cancer is a life-altering diagnosis, not just for patients, but for their loved ones as well. Once, prostate cancer was most frequently diagnosed in men in their 60s and 70s; with increasing use of imaging modalities and PSA testing, the incidence is on the rise, and we are now seeing men in their 40s with the disease. This poses a challenge for clinical management depending on the stage of the disease—from watchful waiting or active surveillance to aggressive treatment with the risk of therapeutic nihilism. Despite being one of the most common cancers in Western men, its natural history, prognosis, and treatment are poorly understood. This book brings together a select faculty of experts to present a comprehensive view of the current state and future perspectives of prostate cancer. There are ten chapters in the book—the first four cover our present knowledge and understanding of the disease, the following three explore new advancements and treatments, particularly looking at overcoming resistance to therapy, and the remaining three chapters focus on specific molecules with the potential to become drug targets. We all have much to learn about prostate cancer. This book is aimed primarily at clinicians and scientists, but many areas will also be of interest to the layperson.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Prostate</subfield><subfield code="x">Cancer.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Epidemiology of Prostate Cancer; Etiology of Prostate Cancer; Pathogenesis of Prostate Cancer; Current Diagnostics for Prostate Cancer; Combination Treatment for Prostate Cancer; Castration-Resistant Prostate Cancer; Theranostics in Metastatic Castrate Resistant Prostate Cancer; Adenocarcinoma of the Prostate; p53 in Prostate Cancer; MUCIN 1 in Prostate Cancer; STEAP Proteins in Prostate Cancer</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">0-645-00175-9</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bott, Simon,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ng, Keng Lim,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-06-11 08:21:35 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2021-12-11 21:44:03 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338833970004498&amp;Force_direct=true</subfield><subfield code="Z">5338833970004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338833970004498</subfield></datafield></record></collection>